Skip to main content
ConductScienceScienceDex

Gary Andrew Weisman

NIH Rank #12795
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1965095Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Biochemistry

NIH Funding · FY2024

Linked Award Amount
$1.1M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#12,795
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Gary Andrew Weisman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Gary Andrew Weisman as a PI. Multi-PI records show the full award amount for context.

  • 5R01DE029833-04R01
    Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
    University of Missouri-Columbia
    $582.7K
    award amount
  • 5R01DE032032-02R01
    The P2X7 receptor for ATP as a therapeutic target in the prevention of radiation-induced salivary gland dysfunction
    University of Missouri-Columbia
    $506.4K
    award amount
  • 3R01DE029833-04S1R01
    Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
    University of Missouri-Columbia
    $59.7K
    award amount

Award organization

Organizations that administered FY2024 awards listing Gary Andrew Weisman as a PI.

FY2024 award administered by University of Missouri-Columbia (MO).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Missouri-Columbia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    R01 Grant Holder

Explore further

Find collaborators for Gary Andrew Weisman

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →